Inicio › Enfermedad de Parkinson › Nueva York
Ensayos clínicos de Enfermedad de Parkinson en Nueva York
32 estudios sobre Enfermedad de Parkinson buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
Visual Hallucinations in Lewy Body Diseases
- NYU Langone Health, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07849413A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-006, Albany
- Site-005, New York
ReclutandoFase 2/3
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06976268GBPDC: Gut-Brain in PD Consortium Master Protocol
- Columbia University, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 21 a 80 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07567794Speech Learning and Speech Production in Parkinson's Disease
- State University of New York at Buffalo, Buffalo
Reclutando
Edades de 45 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07403539Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Weill Cornell Medical College, New York
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07005180A Study of Buntanetap in Participants With PD
- Mount Sinai Hospital, New York
ReclutandoFase 2/3
Edades de 40 a 85 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07284784Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Northwell Health Neuroscience Institute, Great Neck
- University at Buffalo, Williamsville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
ReclutandoFase 2
Edades de 30 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Mount Sinai, New York
- Columbia University, New York
- University of Rochester Medical Center, Rochester
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Northwell Health, New York
- Stony Brook University, Stony Brook
- University of Buffalo Jacobs School of Medicine, Williamsville
ReclutandoEstudio observacional
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07330258Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Albany Medical Center, Albany
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 3 sept 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Dent Neurological Institute, Amherst
- Parkinson's Research Centers of America - Long Island, Commack
- Weill Cornell Medical College, New York
- y 1 más
ReclutandoFase 3
Edades de 50 a 85 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Northwell Health, Manhasset
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
- y 1 más
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 ago 2026 · NCT06680830Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT06993142Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
- NYU Langone Health, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT07752355Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 a 90 · Todos los sexos · Actualizado el 4 ago 2026 · NCT04239079A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- UBMD Neurology, Buffalo
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
ReclutandoFase 3
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06944522Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Radial Midtown Manhattan, New York
Reclutando
Edades de 22 a 80 · Todos los sexos · Actualizado el 31 jul 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
- University of Rochester, Rochester
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT04477785Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
- New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old Westbury
Reclutando
Todas las edades · Todos los sexos · Actualizado el 29 jun 2026 · NCT06671600A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Columbia University, New York
ReclutandoFase 2
Edades de 45 a 75 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06285643Natural History Study of Synucleinopathies
- NYU Medical Center, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT01799915Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- Weill Cornell Medicine, New York
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 22 may 2026 · NCT05347407This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
- Cornell University Weill Medical College, New York
ReclutandoFase 1/2
Edades de 30 a 75 · Todos los sexos · Actualizado el 11 may 2026 · NCT07102342A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Weill Cornell Medicine, New York
ReclutandoEstudio observacional
Edades de 30 a 99 · Todos los sexos · Actualizado el 20 mar 2026 · NCT05539196A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- New York Presbyterian Hospital-Columbia University Medical Center, New York
ReclutandoFase 1/2
Edades de 40 a 72 · Todos los sexos · Actualizado el 2 mar 2026 · NCT06753331Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Albany Medical Center, Albany
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 8 ene 2026 · NCT04071847Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson's Disease and Movement Disorders Center - Long Island, Commack
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2025 · NCT07219927A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Parkinson's Research Centers of America - Long Island, Commack
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2025 · NCT06765668NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
ReclutandoEstudio observacional
30 Days · Todos los sexos · Actualizado el 3 mar 2025 · NCT06203106Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- Teachers College, Columbia University, New York
ReclutandoFase 1 temprana
Edades de 50 a 80 · Todos los sexos · Actualizado el 15 ago 2024 · NCT06540989De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.